Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP8 | P40818 | 1/20 | 0.41 |
| ▸ | USP7 | Q93009 | 1/20 | 0.41 |
| ▸ | USP47 | Q96K76 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2704135 | 1.00 | USP8 (0.41) | USP8USP7USP47KDM4EMAPT | |
| SCHEMBL2706800 | 0.97 | USP8 (0.39) | USP8USP7USP47KDM4EMAPT | |
| SCHEMBL2704147 | 0.95 | USP8 (0.38) | USP8USP7USP47KDM4EMAPT | |
| SCHEMBL2705378 | 0.93 | USP8 (0.43) | USP8USP7USP47MAPT | |
| SCHEMBL2706793 | 0.88 | USP8 (0.40) | USP8USP7USP47 | |
| SCHEMBL2706362 | 0.88 | USP8 (0.40) | USP8USP7USP47 | |
| SCHEMBL2705674 | 0.84 | KDM4E (0.40) | KDM4E | |
| SCHEMBL2705678 | 0.84 | KDM4E (0.40) | KDM4E | |
| SCHEMBL2704127 | 0.83 | RAB9A (0.34) | USP8USP7USP47KDM4EMAPT | |
| SCHEMBL2704133 | 0.83 | RAB9A (0.34) | USP8USP7USP47KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160204361-A1 | CARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT WHICH COMPRISES SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH MANUFACTURED USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-14 | — | — | US | disclosed |
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20150303380-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MAGNOLIA BLUE CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| US-8088901-B2 | Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160197288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR PRODUCING COMPOUND | LEF1, L1CAM, OLA1 | USP8 2712/4885USP7 3670/4885USP47 4231/4885 |
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | CYP19A1, HSD17B2, AZI2 | USP8 4618/4885USP7 3736/4885USP47 3258/4885 |
| US-20160204361-A1 | CARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT WHICH COMPRISES SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH MANUFACTURED USING SAME | L1CAM, EPB41, EPX | USP8 3818/4885USP7 3966/4885USP47 4321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.